Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Relapsing-Remitting Multiple Sclerosis
Interventions
DRUG

Interferon-beta-1a

dosage and frequency as per Biogen Idec protocol

DRUG

methylprednisolone

dosage and frequency as per Biogen Idec protocol

Trial Locations (2)

Unknown

Coordinating Research Site, NSW

Research Site, Hamilton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY